Emma Di Carlo
Chieti, 66100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Interleukin-30 promotes melanoma spreading and triggers LAG-3 expression and T cell exhaustion.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 21, 2025
Pazopanib-associated remodeling of platelet-immune cell crosstalk and immune suppressive platelet-derived extracellular vesicles in metastatic RCC.
Journal: Frontiers in immunology
Published: August 31, 2025
Targeting the cancer metabolism-immunity interface: update and perspectives.
Journal: Experimental hematology & oncology
Published: August 29, 2025
Prostatic fibroblast reprogramming by Interleukin-30 activates prostate cancer metastasis programs.
Journal: Molecular biomedicine
Published: August 25, 2025
Tumor-on-chip's alliance with molecular pathology against metastatic disease.
Journal: Journal of biomedical science
Published: July 31, 2025
State of the art CRISPR-based strategies for cancer diagnostics and treatment.
Journal: Biomarker research
Published: September 20, 2024
Oxidative Stress and Age-Related Tumors.
Journal: Antioxidants (Basel, Switzerland)
Published: July 19, 2024
Prevention of prostate cancer metastasis by a CRISPR-delivering nanoplatform for interleukin-30 genome editing.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 10, 2024
The multifaceted role of the stroma in the healthy prostate and prostate cancer.
Journal: Journal of translational medicine
Published: April 12, 2024
Immunoliposome-based targeted delivery of the CRISPR/Cas9gRNA-IL30 complex inhibits prostate cancer and prolongs survival.
Journal: Experimental & molecular medicine
Published: February 05, 2024
Last Updated: 09/26/2026